SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-18-000082
Filing Date
2018-05-14
Accepted
2018-05-14 17:03:01
Documents
41
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED MARCH 31, 2018 bivi-20180331_10q.htm 10-Q 210515
2 EXHIBIT 31.1 bivi-20180331_10qex31z1.htm EX-31.1 12106
3 EXHIBIT 32.1 bivi-20180331_10qex32z1.htm EX-32.1 5796
  Complete submission text file 0001520138-18-000082.txt   1425592

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bivi-20180331.xml EX-101.INS 205339
5 XBRL CALCULATION FILE bivi-20180331_cal.xml EX-101.CAL 29251
6 XBRL DEFINITION FILE bivi-20180331_def.xml EX-101.DEF 37099
7 XBRL LABEL FILE bivi-20180331_lab.xml EX-101.LAB 131398
8 XBRL PRESENTATION FILE bivi-20180331_pre.xml EX-101.PRE 101461
9 XBRL SCHEMA FILE bivi-20180331.xsd EX-101.SCH 20080
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 312-283-5793
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 18831651
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1